INVESTORS
Analyst & Investor Call to Discuss Sierra’s Acquisition of Momelotinib from Gilead
Thursday, August 23, 2018
4:00pm EDT

Members of the professional investment community may participate by phone by calling:
Toll-free in North America: (866) 548-4713
International Dial-in: (323) 794-2093
Conference ID: 6356543